Paolo Ricchi

1.9k total citations
88 papers, 1.2k citations indexed

About

Paolo Ricchi is a scholar working on Genetics, Hematology and Epidemiology. According to data from OpenAlex, Paolo Ricchi has authored 88 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 51 papers in Hematology and 13 papers in Epidemiology. Recurrent topics in Paolo Ricchi's work include Hemoglobinopathies and Related Disorders (65 papers), Iron Metabolism and Disorders (46 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Paolo Ricchi is often cited by papers focused on Hemoglobinopathies and Related Disorders (65 papers), Iron Metabolism and Disorders (46 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Paolo Ricchi collaborates with scholars based in Italy, Greece and United States. Paolo Ricchi's co-authors include Angela M. Acquaviva, Raffaele Zarrilli, Sandro Pignata, Anna Spasiano, Tiziana Di Matola, Anna Apicella, Silvia Costantini, Patrizia Cinque, Aldo Filosa and Massimiliano Ammirabile and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Paolo Ricchi

81 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Ricchi Italy 18 455 390 218 175 150 88 1.2k
Erica Sparkenbaugh United States 21 393 0.9× 497 1.3× 467 2.1× 43 0.2× 92 0.6× 43 1.5k
Güray Saydam Türkiye 22 515 1.1× 678 1.7× 533 2.4× 55 0.3× 278 1.9× 160 1.6k
Brigitte Kaiser Germany 17 128 0.3× 435 1.1× 315 1.4× 188 1.1× 153 1.0× 61 1.6k
Jacques Himber Switzerland 16 260 0.6× 1.1k 2.9× 501 2.3× 46 0.3× 77 0.5× 29 2.0k
Charlotte van Kesteren Netherlands 22 88 0.2× 747 1.9× 256 1.2× 163 0.9× 375 2.5× 45 1.6k
Marie‐Camille Chaumais France 24 277 0.6× 162 0.4× 332 1.5× 45 0.3× 133 0.9× 64 1.8k
Elisabeth Koller Austria 23 185 0.4× 720 1.8× 481 2.2× 68 0.4× 257 1.7× 75 1.7k
Jianlin Qiao China 20 121 0.3× 508 1.3× 612 2.8× 52 0.3× 402 2.7× 108 1.6k
G. Defreyn Belgium 20 64 0.1× 406 1.0× 289 1.3× 223 1.3× 54 0.4× 34 1.7k
Mamdooh Gari Saudi Arabia 20 317 0.7× 701 1.8× 738 3.4× 19 0.1× 232 1.5× 69 1.7k

Countries citing papers authored by Paolo Ricchi

Since Specialization
Citations

This map shows the geographic impact of Paolo Ricchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ricchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ricchi more than expected).

Fields of papers citing papers by Paolo Ricchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Ricchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ricchi. The network helps show where Paolo Ricchi may publish in the future.

Co-authorship network of co-authors of Paolo Ricchi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Ricchi. A scholar is included among the top collaborators of Paolo Ricchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Ricchi. Paolo Ricchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taher, Alì, Vip Viprakasit, Antonis Kattamis, et al.. (2025). Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study. Blood Advances. 9(23). 6108–6119.
2.
Musallam, Khaled M., Angela Vitrano, Rosario Di Maggio, et al.. (2025). Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐LIGHT study. British Journal of Haematology. 207(4). 1578–1588.
3.
Meloni, Antonella, Laura Pistoia, Paolo Ricchi, et al.. (2024). Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients. Journal of Clinical Medicine. 13(16). 4791–4791.
4.
Meloni, Antonella, Laura Pistoia, Paolo Ricchi, et al.. (2024). Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network. La radiologia medica. 129(6). 879–889. 1 indexed citations
5.
Taher, Alì, Hanny Al‐Samkari, Yeşim Aydınok, et al.. (2024). ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA. Hematology Transfusion and Cell Therapy. 46. S32–S33. 1 indexed citations
6.
Meloni, Antonella, Laura Pistoia, Paolo Ricchi, et al.. (2023). Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia. Journal of Clinical Medicine. 12(18). 6015–6015. 3 indexed citations
7.
Longo, Filomena, Irene Motta, Valeria Maria Pinto, et al.. (2023). Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence. Journal of Clinical Medicine. 12(7). 2584–2584. 5 indexed citations
8.
Meloni, Antonella, Laura Pistoia, Riccardo Righi, et al.. (2023). Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience. Tomography. 9(5). 1711–1722. 1 indexed citations
9.
Taher, Alì, Vip Viprakasit, Antonis Kattamis, et al.. (2023). Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial. Blood. 142(Supplement 1). 3847–3847. 2 indexed citations
10.
Meloni, Antonella, Laura Pistoia, Maria Rita Gamberini, et al.. (2023). The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network. European Journal of Internal Medicine. 114. 93–100. 2 indexed citations
11.
Meloni, Antonella, Laura Pistoia, Paolo Ricchi, et al.. (2022). Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy. Blood Advances. 7(10). 2237–2240. 7 indexed citations
12.
Cennamo, Gilda, Daniela Montorio, Paolo Ricchi, et al.. (2021). Retinal and Choriocapillaris Vascular Changes in Patients Affected by Different Clinical Phenotypes of β-Thalassemia: An Optical Coherence Tomography Angiography Study. Biology. 10(4). 276–276. 4 indexed citations
13.
Ricchi, Paolo, Silvia Costantini, Anna Spasiano, et al.. (2019). Rechallenging to Hydroxycarbamide Post Thalidomide Treatment and Response in a Non Transfusion-Dependent Patient, is it Possible?. Indian Journal of Hematology and Blood Transfusion. 35(3). 587–589. 1 indexed citations
14.
Marsella, Maria & Paolo Ricchi. (2019). <p>Thalassemia and hepatocellular carcinoma: links and risks</p>. Journal of Blood Medicine. Volume 10. 323–334. 13 indexed citations
15.
Marsella, Maria, Massimiliano Ammirabile, Tiziana Di Matola, et al.. (2018). Is there a difference in phenotype between males and females with non-transfusion-dependent thalassemia? A cross-sectional evaluation. Hematology. 23(8). 522–525. 11 indexed citations
16.
Ricchi, Paolo, Silvia Costantini, Anna Spasiano, et al.. (2011). A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient. Acta Haematologica. 125(4). 222–224. 2 indexed citations
17.
Ricchi, Paolo, Massimiliano Ammirabile, & Aurelio Maggio. (2010). Hypocholesterolaemia in Thalassaemia – Pathogenesis, Implications and Clinical Effects. European Oncology & Haematology. 0(4). 20–20. 6 indexed citations
18.
Ricchi, Paolo, Massimiliano Ammirabile, Anna Spasiano, et al.. (2008). Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients. European Journal Of Haematology. 82(3). 219–222. 19 indexed citations
19.
Ricchi, Paolo, et al.. (2003). Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. British Journal of Cancer. 88(6). 803–807. 106 indexed citations
20.
Ricchi, Paolo, et al.. (2003). Aspirin Protects Caco-2 Cells from Apoptosis after Serum Deprivation through the Activation of a Phosphatidylinositol 3-Kinase/AKT/p21/1Pathway. Molecular Pharmacology. 64(2). 407–414. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica Sparkenbaugh Breakdown of academic impact, for papers by Güray Saydam Breakdown of academic impact, for papers by Brigitte Kaiser Breakdown of academic impact, for papers by Jacques Himber Breakdown of academic impact, for papers by Charlotte van Kesteren Breakdown of academic impact, for papers by Marie‐Camille Chaumais Breakdown of academic impact, for papers by Elisabeth Koller Breakdown of academic impact, for papers by Jianlin Qiao Breakdown of academic impact, for papers by G. Defreyn Breakdown of academic impact, for papers by Mamdooh Gari
Rankless by CCL
2026